Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trialMilagritos D. Tapia, Myron M. Levine, Awa Traoré et al.|The Lancet Infectious Diseases|2015Cited by 217
Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trialMilagritos D. Tapia, Abena Kunadu Yawson, Samba O. Sow et al.|The Lancet Infectious Diseases|2020Cited by 76
Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trialMilagritos D. Tapia, Abena Kunadu Yawson, Samba O. Sow et al.|The Lancet Infectious Diseases|2020Cited by 65